HCA Healthcare (NYSE: HCA) details latest insider transactions
HCA Healthcare (HCA) filed a Form 4 with the SEC, detailing insider transactions. EVP Michael R. McAlevey sold 7,769 shares at $429 each, with holdings adjusted across various trusts. The transactions did not change total beneficial ownership. Prices were based on the average of high and low shares on the transaction date.
How this was made
The 30-second read
Why it matters
The transaction does not change total beneficial ownership and is unlikely to influence market perception or price.
Market read
A modest insider transfer with no ownership change; low trading relevance.
What to watch
The filing notes a simultaneous transfer back to the trust, suggesting the move may be purely administrative rather than a confidence signal.
Background
Form 4 filing disclosed an insider trust-to-direct share transfer by HCA's EVP, a routine corporate governance event.
Ticker impact
EVP & Chief Legal & Admin Officer Michael R. McAlevey transferred 7,769 shares (≈$3.33M) from a trust to direct ownership on Aug 26, 2026.
No material move expected; share price likely unchanged.
Form 4 filing is primary source, but the transaction size is modest for a large cap and does not alter ownership concentration.
Market effects
None; insider activity does not affect the broader healthcare services sector.
No regional effect; transaction is confined to HCA shareholders.
Minimal; HCA is a US health‑care operator with limited global ripple.
Counterpoint
If the trust transfer signals upcoming liquidity needs, a short‑term dip could be possible, but evidence is weak.
Key entities
- CompanyHCA Healthcare, Inc.
US‑listed health‑care services provider (NYSE:HCA).
- ExecutiveMichael R. McAlevey
EVP & Chief Legal & Admin Officer of HCA.
